Drug Shortage Report for TARO-DOCUSATE
| Report ID | 91811 |
| Drug Identification Number | 00716731 |
| Brand name | TARO-DOCUSATE |
| Common or Proper name | TARO-DOCUSATE |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DOCUSATE SODIUM |
| Strength(s) | 100MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 1000 |
| ATC code | A06AA |
| ATC description | DRUGS FOR CONSTIPATION |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-08-15 |
| Estimated end date | 2019-09-13 |
| Actual end date | 2019-09-13 |
| Shortage status | Resolved |
| Updated date | 2019-09-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2019-09-14 | English | Compare |
| v6 | 2019-09-13 | French | Compare |
| v5 | 2019-09-13 | English | Compare |
| v4 | 2019-09-09 | French | Compare |
| v3 | 2019-09-09 | English | Compare |
| v2 | 2019-08-19 | French | Compare |
| v1 | 2019-08-19 | English | Compare |
Showing 1 to 7 of 7